Back to Search
Start Over
Impact of Spores on the Comparative Efficacies of Five Antibiotics for Treatment of Bacillus anthracis in an In Vitro Hollow Fiber Pharmacodynamic Model
- Source :
- Antimicrobial Agents and Chemotherapy. 56:1229-1239
- Publication Year :
- 2012
- Publisher :
- American Society for Microbiology, 2012.
-
Abstract
- Bacillus anthracis , the bacterium that causes anthrax, is an agent of bioterrorism. The most effective antimicrobial therapy for B. anthracis infections is unknown. An in vitro pharmacodynamic model of B. anthracis was used to compare the efficacies of simulated clinically prescribed regimens of moxifloxacin, linezolid, and meropenem with the “gold standards,” doxycycline and ciprofloxacin. Treatment outcomes for isogenic spore-forming and non-spore-forming strains of B. anthracis were compared. Against spore-forming B. anthracis , ciprofloxacin, moxifloxacin, linezolid, and meropenem reduced the B. anthracis population by 4 log 10 CFU/ml over 10 days. Doxycycline reduced the population of this B. anthracis strain by 5 log 10 CFU/ml (analysis of variance [ANOVA] P = 0.01 versus other drugs). Against an isogenic non-spore-forming strain, meropenem killed the vegetative B. anthracis the fastest, followed by moxifloxacin and ciprofloxacin and then doxycycline. Linezolid offered the lowest bacterial kill rate. Heat shock studies using the spore-producing B. anthracis strain showed that with moxifloxacin, ciprofloxacin, and meropenem therapies the total population was mostly spores, while the population was primarily vegetative bacteria with linezolid and doxycycline therapies. Spores have a profound impact on the rate and extent of killing of B. anthracis . Against spore-forming B. anthracis , the five antibiotics killed the total (spore and vegetative) bacterial population at similar rates (within 1 log 10 CFU/ml of each other). However, bactericidal antibiotics killed vegetative B. anthracis faster than bacteriostatic drugs. Since only vegetative-phase B. anthracis produces the toxins that may kill the infected host, the rate and mechanism of killing of an antibiotic may determine its overall in vivo efficacy. Further studies are needed to examine this important observation.
- Subjects :
- medicine.drug_class
Moxifloxacin
Antibiotics
Population
Microbial Sensitivity Tests
Models, Biological
Meropenem
Microbiology
chemistry.chemical_compound
Ciprofloxacin
Predictive Value of Tests
Acetamides
medicine
Experimental Therapeutics
Pharmacology (medical)
education
Oxazolidinones
Spores, Bacterial
Pharmacology
Doxycycline
Aza Compounds
education.field_of_study
Microbial Viability
biology
fungi
Linezolid
biochemical phenomena, metabolism, and nutrition
Viral Load
bacterial infections and mycoses
biology.organism_classification
Virology
Anti-Bacterial Agents
Bacillus anthracis
Infectious Diseases
chemistry
Quinolines
Thienamycins
Fluoroquinolones
medicine.drug
Subjects
Details
- ISSN :
- 10986596 and 00664804
- Volume :
- 56
- Database :
- OpenAIRE
- Journal :
- Antimicrobial Agents and Chemotherapy
- Accession number :
- edsair.doi.dedup.....5d355afa88d9af25dbafa2f97d323513
- Full Text :
- https://doi.org/10.1128/aac.01109-10